Latest Updates
-
Happy Birthday Dheeraj Dhoopar: How A TV Set Friendship Turned Into Love With Wife Vinny Arora -
Top Skin and Hair Concerns in India in 2025: What the Data Reveals -
International Human Solidarity Day 2025: History, Significance, and Why It Matters -
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet -
A Hotel on Wheels: Bihar Rolls Out Its First Luxury Caravan Buses -
Bharti Singh-Haarsh Limbachiyaa Welcome Second Child, Gender: Couple Welcome Their Second Baby, Duo Overjoyed - Report | Bharti Singh Gives Birth To Second Baby Boy | Gender Of Bharti Singh Haarsh Limbachiyaa Second Baby -
Bharti Singh Welcomes Second Son: Joyous News for the Comedian and Her Family -
Gold & Silver Rates Today in India: 22K, 24K, 18K & MCX Prices Fall After Continuous Rally; Check Latest Gold Rates in Chennai, Mumbai, Bangalore, Hyderabad, Ahmedabad & Other Cities on 19 December -
Nick Jonas Dancing to Dhurandhar’s “Shararat” Song Goes Viral -
From Consciousness To Cosmos: Understanding Reality Through The Vedic Lens
Alembic Pharma Gets Tentative USFDA Approval For Depressive Disorder Drug
Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic Vortioxetine tablets indicated for the treatment of the major depressive disorder.

The tentative approval granted by the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Vortioxetine tablets of strengths in 5 mg, 10 mg, 15 mg and 20 mg, the company said in a statement.
These are therapeutically equivalent to the reference listed drug product (RLD) Trintellix tablets 5 mg, 10 mg, 15 mg, and 20 mg of Takeda Pharmaceuticals, USA, Inc, it added. Citing IQVIA data, the company said.
These Vortioxetine tablets have an estimated market size of USD 1,249 million for twelve months ending September 2021. Citing IQVIA data, the company said these Vortioxetine tablets have an estimated market size of USD 1,249 million for twelve months ending September 2021.
Alembic, however, said it is currently in litigation with H Lundbeck in the Court of appeals for the Federal Circuit and the launch of the product will depend on litigation outcome.
"It is possible that our ANDA may not be indicated for certain uses due to unexpired exclusivities for the RLD for such uses," the company said.
Image Source: Freepik.com
Mental
Health
Helpline
Numbers:
1.
COOJ
Mental
Health
Foundation
(COOJ)-
Helpline:
0832-2252525
|
01:00
PM
-
07:00
PM
(Monday
to
Friday)
2.
Parivarthan-
Helpline:
+91
7676
602
602
|
10:00
AM
to
10:00
PM
(Monday
to
Friday)
3.
Connecting
Trust-
Helpline:
+91
992
200
1122
|
+91-992
200
4305
|
12:00
PM
to
08:00
PM
(All
days
of
the
week)
4.
Roshni
Trust-
Helpline:
040-66202000,
040-66202001
|
11:00
AM
-
09:00
PM
(Monday
to
Sunday)
5.
Sahai
Helpline:
080-25497777
/
Email
at
-
SAHAIHELPLINE@GMAIL.COM
|
10
AM-
8
PM
(Monday
to
Saturday)
6.
Sumaitri:
011-23389090
/
FEELINGSUICIDAL@SUMAITRI.NET
|2
PM-
10
PM
(Monday
To
Friday);
10
AM
-
10
PM
(Saturday
and
Sunday)
7.
Sneha:
044-24640050
(24
HOURS)
/
044-24640060
|
Email
at-
HELP@SNEHAINDIA.ORG
|8
AM
-
10
PM
8.
Lifeline:
033-24637401
/
033-24637432
|
Email
at
LIFELINEKOLKATA@GMAIL.COM
|
10
AM
-
6
PM.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











